Ligachem Biosciences, Inc.

This study tested if adding a new drug called delpazolid to a standard three-drug tuberculosis (TB) treatment was safe and effective. It involved 76 adults with newly diagnosed, drug-sensitive lung TB. Researchers compared different doses of the new combination to the standard tr…